Pliant Therapeutics Inc (PLRX)
12.85
-0.92
(-6.68%)
USD |
NASDAQ |
Nov 14, 16:00
12.85
0.00 (0.00%)
After-Hours: 17:10
Pliant Therapeutics Total Assets (Quarterly): 445.66M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 445.66M |
| June 30, 2024 | 483.73M |
| March 31, 2024 | 521.60M |
| December 31, 2023 | 512.15M |
| September 30, 2023 | 540.46M |
| June 30, 2023 | 574.89M |
| March 31, 2023 | 597.88M |
| December 31, 2022 | 350.61M |
| September 30, 2022 | 377.18M |
| June 30, 2022 | 184.62M |
| Date | Value |
|---|---|
| March 31, 2022 | 197.02M |
| December 31, 2021 | 221.22M |
| September 30, 2021 | 234.12M |
| June 30, 2021 | 255.72M |
| March 31, 2021 | 275.25M |
| December 31, 2020 | 295.53M |
| September 30, 2020 | 312.32M |
| June 30, 2020 | 328.80M |
| March 31, 2020 | 184.06M |
| December 31, 2019 | 119.06M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
119.06M
Minimum
Dec 2019
597.88M
Maximum
Mar 2023
350.60M
Average
320.56M
Median
Total Assets (Quarterly) Benchmarks
| Haemonetics Corp | 2.525B |
| Marker Therapeutics Inc | 11.68M |
| Aligos Therapeutics Inc | 88.43M |
| Korro Bio Inc | 249.59M |
| CEL-SCI Corp | 24.07M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 99.84M |
| Shareholders Equity (Quarterly) | 345.82M |